drugset / Trial / NCT07555769

Calcium Electroporation for Urinary Bladder Tumors: A First-in-Human Feasibility, Safety, and Early Response Trial

NCT07555769

Phase 1 Not yet recruiting 20 enrolled Juan Luis Vásquez
NaSingle-groupOpen-labelOther

Summary

This phase I study evaluates intravesical calcium electroporation (CaEP) with a new transurethral electrode. The study is primarily designed to assess the safety of CaEP and secondarily, to preliminary explore the efficacy in patients with limited alternative therapies. The anticipated benefits and structured safety precautions justify the ethical conduct of the investigation.

Timeline

Start
2026-06
Primary completion
2030-04
Completion
2030-04

Drugs

EvaluationDrugModalityDoseRoute
Subject calcium gluconate Small molecule Other